Author: Brittney Wheeler

Washington University faculty, staff and students are encouraged to explore and use WashUReuse. The platform promotes peer-to-peer sharing of unwanted items such as equipment, supplies and furniture, reducing costs and keeping items out of landfills. 

School of Medicine scientists are working to minimize the risk of another devastating coronavirus pandemic by designing a vaccine that reduces sickness and death caused by all potentially deadly coronaviruses, including ones that have not yet affected people. The research is supported by an $8 million grant from the National Institutes of Health (NIH).

Daniel C. Link, MD, a highly regarded physician-scientist who treats patients with leukemia and also conducts innovative research, has been named director of the Division of Oncology in the Department of Medicine at the School of Medicine.

The School of Medicine’s Cynthia Rogers, MD, and co-investigator Christopher Smyser, MD, have received a MERIT award from the National Institutes of Health (NIH) to support their research focused on preterm babies’ brains as the children age.

Washington University Emergency Management plans to test its emergency communication system at 10 a.m. Tuesday, April 4. The test ensures that the university can effectively communicate with its community in an emergency.

Makedonka Mitreva, a professor of medicine and of genetics at the School of Medicine, has been elected to the American Academy of Microbiology in recognition of her contributions to the field of microbiology.

People infected with COVID-19 who then took the antiviral medication Paxlovid within five days after testing positive experienced a reduced risk of long-term health problems, hospitalization and death for up to six months, according to a study by researchers at the School of Medicine and the Veterans Affairs St. Louis Health Care system.

Susan Shannon, an accounting and payroll assistant in the Office of Graduate Studies in Arts & Sciences, died of cancer March 16, 2023, at her home. She was 60. 

New research led by Washington University researchers identifies a common genetic signature that may increase a person’s risk of developing substance use disorders. The work eventually could lead to universal therapies to treat multiple substance use disorders and potentially help people diagnosed with more than one.

New research from the School of Medicine’s Guoyan Zhao and colleagues provides guidance for future study to understand the role of glia in disease pathogenesis using mouse models. The work is published in Nature Aging.